{"id":"NCT02071082","sponsor":"Gilead Sciences","briefTitle":"Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults","officialTitle":"A Phase 3b Open-label Study of the Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen in HIV-1/Hepatitis B Co-infected Adults","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-02-25","primaryCompletion":"2015-01-23","completion":"2016-10-26","firstPosted":"2014-02-25","resultsPosted":"2016-04-04","lastUpdate":"2018-11-16"},"enrollment":79,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["HIV","HBV"],"interventions":[{"type":"DRUG","name":"E/C/F/TAF","otherNames":["Genvoya®"]}],"arms":[{"label":"HIV treatment-naive and HBV treatment-naive","type":"EXPERIMENTAL"},{"label":"HIV-suppressed","type":"EXPERIMENTAL"}],"summary":"This study will assess the efficacy, safety, and tolerability of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) fixed-dose combination (FDC) in human immunodeficiency virus (HIV)/hepatitis B virus (HBV) coinfected adults.\n\nParticipants will be enrolled into two cohorts:\n\n* Cohort 1: HIV/HBV coinfected adults who are HIV treatment-naive and HBV treatment-naive\n* Cohort 2: HIV/HBV coinfected adults who are HIV-suppressed","primaryOutcome":{"measure":"Percentage of Participants With Plasma HIV-1 RNA Level < 50 Copies/mL","timeFrame":"Week 24","effectByArm":[{"arm":"HIV/HBV Treatment-Naive","deltaMin":100,"sd":null},{"arm":"HIV-Suppressed","deltaMin":94.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":12},"locations":{"siteCount":24,"countries":["United States","Canada","Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":3},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Diarrhoea","Gastrooesophageal reflux disease","Bronchitis"]}}